Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A group of central nervous system neoplasms with a variable amount of neuronal and, less consistently, glial differentiation. They occur at a low frequency and usually carry a favorable prognosis. Representative examples include dysplastic cerebellar gangliocytoma, desmoplastic infantile ganglioglioma, desmoplastic infantile astrocytoma, and dysembryoplastic neuroepithelial tumor. (Adapted from WHO)
Biomarker and diagnostic research for mixed neuronal-glial tumor has been reported in the published literature.
No clinical trials have been registered for mixed neuronal-glial tumor.
3 publications have been identified in PubMed for mixed neuronal-glial tumor. Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Case Report / Case Series (33%).
van den Bent MJ (2025). [PMID: 39387386](https://pubmed.ncbi.nlm.nih.gov/39387386/). *Neuro Oncol*. [Review / Meta-Analysis]
Shintaku M (2024). [PMID: 39114504](https://pubmed.ncbi.nlm.nih.gov/39114504/). *Int J Clin Exp Pathol*. [Case Report / Case Series]
Liu P (2024). [PMID: 39040377](https://pubmed.ncbi.nlm.nih.gov/39040377/). *Heliyon*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 10:42 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center